table of content
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Nuclear Medicine Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Nuclear Medicine Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Nuclear Medicine Diagnostics Overall Market Size
2.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size: 2021 VS 2028
2.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Nuclear Medicine Diagnostics Players in Global Market
3.2 Top Global Prostate Cancer Nuclear Medicine Diagnostics Companies Ranked by Revenue
3.3 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Nuclear Medicine Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Prostate Cancer Nuclear Medicine Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Nuclear Medicine Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Nuclear Medicine Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Nuclear Medicine Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Markets, 2021 & 2028
4.1.2 SPECT
4.1.3 PET
4.2 By Type - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2017-2022
4.2.2 By Type - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2023-2028
4.2.3 By Type - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2017-2022
5.2.2 By Application - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2023-2028
5.2.3 By Application - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2017-2022
6.2.2 By Region - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2023-2028
6.2.3 By Region - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2017-2028
6.3.2 US Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
6.3.3 Canada Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
6.3.4 Mexico Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2017-2028
6.4.2 Germany Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
6.4.3 France Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
6.4.4 U.K. Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
6.4.5 Italy Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
6.4.6 Russia Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
6.4.7 Nordic Countries Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
6.4.8 Benelux Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2017-2028
6.5.2 China Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
6.5.3 Japan Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
6.5.4 South Korea Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
6.5.5 Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
6.5.6 India Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2017-2028
6.6.2 Brazil Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
6.6.3 Argentina Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2017-2028
6.7.2 Turkey Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
6.7.3 Israel Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
6.7.4 Saudi Arabia Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
6.7.5 UAE Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
7 Players Profiles
7.1 Blue Earth Diagnostics
7.1.1 Blue Earth Diagnostics Corporate Summary
7.1.2 Blue Earth Diagnostics Business Overview
7.1.3 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.1.4 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
7.1.5 Blue Earth Diagnostics Key News
7.2 PETNET Solutions
7.2.1 PETNET Solutions Corporate Summary
7.2.2 PETNET Solutions Business Overview
7.2.3 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.2.4 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
7.2.5 PETNET Solutions Key News
7.3 Cardinal Health
7.3.1 Cardinal Health Corporate Summary
7.3.2 Cardinal Health Business Overview
7.3.3 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.3.4 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
7.3.5 Cardinal Health Key News
7.4 Lantheus Medical Imaging
7.4.1 Lantheus Medical Imaging Corporate Summary
7.4.2 Lantheus Medical Imaging Business Overview
7.4.3 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.4.4 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
7.4.5 Lantheus Medical Imaging Key News
7.5 Jubilant Pharma
7.5.1 Jubilant Pharma Corporate Summary
7.5.2 Jubilant Pharma Business Overview
7.5.3 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.5.4 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
7.5.5 Jubilant Pharma Key News
7.6 NCM-USA
7.6.1 NCM-USA Corporate Summary
7.6.2 NCM-USA Business Overview
7.6.3 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.6.4 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
7.6.5 NCM-USA Key News
7.7 Progenics Pharma
7.7.1 Progenics Pharma Corporate Summary
7.7.2 Progenics Pharma Business Overview
7.7.3 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.7.4 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
7.7.5 Progenics Pharma Key News
7.8 Telix Pharma
7.8.1 Telix Pharma Corporate Summary
7.8.2 Telix Pharma Business Overview
7.8.3 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.8.4 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
7.8.5 Telix Pharma Key News
7.9 ImaginAb
7.9.1 ImaginAb Corporate Summary
7.9.2 ImaginAb Business Overview
7.9.3 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.9.4 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
7.9.5 ImaginAb Key News
7.10 Theragnostics
7.10.1 Theragnostics Corporate Summary
7.10.2 Theragnostics Business Overview
7.10.3 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.10.4 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
7.10.5 Theragnostics Key News
7.11 Novartis
7.11.1 Novartis Corporate Summary
7.11.2 Novartis Business Overview
7.11.3 Novartis Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.11.4 Novartis Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
7.11.5 Novartis Key News
7.12 Alliance Medical
7.12.1 Alliance Medical Corporate Summary
7.12.2 Alliance Medical Business Overview
7.12.3 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.12.4 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
7.12.5 Alliance Medical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
